Farhana Akter

1.0k citations
53 papers · 515 indexed · h-index 11
Topics
COVID-19 Clinical Research Studies (7 papers)Diabetes and associated disorders (4 papers)Diabetes Treatment and Management (3 papers)

In The Last Decade

Farhana Akter

47 papers receiving 496 citations

Peers

Farhana Akter
Comparison fields: 5 of 124
  • Surgery 79
  • Endocrinology, Diabetes and Metabolism 72
  • Neurology 67
  • Infectious Diseases 66
  • Molecular Biology 61
Replace Yanmei Liu with:
Yanmei Liu China
Simin Deng China
Niloofar Deravi Iran
Siyu Yang China
Ashish Anjankar India
Maurice Alexander United States
Madhan Krishnan India
Hossein Alikhah Iran
Farhana Akter relative to Yanmei Liu China Yanmei Liu's profile →
Citations per field
00.5×1.5×1.9×
Yanmei Liu · 1×
Citations per year

Countries citing papers authored by Farhana Akter

Since Specialization
Citations

This map shows the geographic impact of Farhana Akter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhana Akter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhana Akter more than expected).

Fields of papers citing papers by Farhana Akter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhana Akter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhana Akter. The network helps show where Farhana Akter may publish in the future.

Co-authorship network of co-authors of Farhana Akter

This figure shows the co-authorship network connecting the top 25 collaborators of Farhana Akter. A scholar is included among the top collaborators of Farhana Akter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhana Akter. Farhana Akter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 1
5 12
6 8
7 5
8 7
9 3
10 3
11 24
12 46
13 10
14 48
15
Antinociceptive activity evaluation of leaves of Malva verticillata L.
2
16 0
17 37
18 1
19 0
20 65

About Farhana Akter

Farhana Akter is a scholar working on Family Practice, Endocrinology, Diabetes and Metabolism and Infectious Diseases, having authored 53 papers that have together received 515 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), Diabetes and associated disorders (4 papers) and Diabetes Treatment and Management (3 papers). The work is most often cited by research in Family Practice (22 citations), Drug Discovery (1 citation) and Otorhinolaryngology (20 citations). Farhana Akter has collaborated with scholars based in Bangladesh, United Kingdom and Malaysia. Frequent co-authors include Mark Kotter, Adnan Mannan, Mohammad Nazrul Islam Bhuiyan, Jaripa Begum, Md. Mahbub Hasan, Nadine L. de Boer, Neil Bulstrode, Ken Stewart, Hiroaki Wakimoto and Navid Redjal. Their work appears in journals such as PLoS ONE, Frontiers in Microbiology and BMC Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026